Skip to main content
Caplight Logo









Danlu Capital

Danlu Capital

Overview

Danlu Capital is a venture capital firm focused on early and growth-stage investments in the medical innovation field, including medical technologies, innovative drugs, and novel medical services.

Year Founded

2018

Portfolio Companies

8

Investments

Danlu Capital investments
CompanyDateStageLead
Juventas Cell Therapy Ltd.Oct 2021Series CCo-investor
Guangzhou Xinji Pharmaceutical Co., Ltd.Dec 2021VC RoundLead
Manteia Technologies Co., Ltd.Dec 2020Series ACo-investor
Beijing Genecradle Therapeutics Co., Ltd.Dec 2023Series ALead
Daobo Medical Technology (Beijing) Co., Ltd.Dec 2021AngelCo-investor
Book a demo to see all 8 portfolio companies

For institutional investors. Book with your work email.

Key People

Cherry Lu

Founding & Executive Partner

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Portfolio analytics

Caplight clients see full sector, stage and valuation breakdowns for this investor.

Book a demo to see full analytics

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Portfolio analytics

Caplight clients see yearly investment pace and funding raised over time.

Book a demo to see full analytics

For institutional investors. Book with your work email.

FAQ

Where is Danlu Capital based?

Danlu Capital is headquartered in Guangzhou, China.

When was Danlu Capital founded?

Danlu Capital was founded in 2018.

How many portfolio companies does Danlu Capital have?

Danlu Capital has 8 portfolio companies in Caplight's dataset.

What are some companies in Danlu Capital's portfolio?

Portfolio companies visible on Caplight include Juventas Cell Therapy Ltd., Guangzhou Xinji Pharmaceutical Co., Ltd., Manteia Technologies Co., Ltd., Beijing Genecradle Therapeutics Co., Ltd., Daobo Medical Technology (Beijing) Co., Ltd..

What was Danlu Capital's most recent investment shown here?

Danlu Capital's most recent investment in this portfolio sample was in Beijing Genecradle Therapeutics Co., Ltd. in 2023.

What sectors does Danlu Capital focus on?

Danlu Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech, Enterprise Software, Enterprise Software.

What company stages does Danlu Capital focus on?

Stage focus information for Danlu Capital is not publicly available.

What is Danlu Capital's AUM?

Danlu Capital's assets under management are estimated between $544.0M and $572.0M.

Firmographic Details

HeadquartersGuangzhou
Year Founded2018

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?